Group 1 - The company announced the conversion and share changes related to its convertible bonds for the third quarter of 2025 [3][11] - The company issued 7.38 million convertible bonds with a total value of 738 million yuan, each with a face value of 100 yuan [3][4] - The initial conversion price of the convertible bonds was set at 21.50 yuan per share, which has undergone several adjustments due to stock buybacks and equity distributions [6][7][8] Group 2 - As of September 30, 2025, the remaining balance of convertible bonds was 224,584,100 yuan, equivalent to 2,245,841 bonds [11] - In the third quarter of 2025, the company experienced a reduction of 615,000 yuan (6,150 bonds) due to conversions, resulting in an increase of 29,785 shares [11] - The company also reported a reduction of 7,000 yuan (70 bonds) due to bond redemptions [11]
上海科华生物工程股份有限公司关于2025年第三季度可转债转股情况的公告